GLUFOSFAMIDE COMBINATION THERAPIES FOR CANCER

The invention provides compositions and methods for treating cancer with glufosfamide in combination with an inhibitor of sodium-glucose transporter type 2 (SGLT2) to block the uptake of glucose in the proximal tubules of the kidneys to decrease renal toxicity. The invention relates to the fields of...

Full description

Saved in:
Bibliographic Details
Main Authors PARRIS, MATTHEW, ANTHONY, FORREST, H, THOMAS, EDWIN, J
Format Patent
LanguageEnglish
French
Published 24.10.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention provides compositions and methods for treating cancer with glufosfamide in combination with an inhibitor of sodium-glucose transporter type 2 (SGLT2) to block the uptake of glucose in the proximal tubules of the kidneys to decrease renal toxicity. The invention relates to the fields of biomedicine, pharmacology, and molecular biology. L'invention concerne des compositions et des méthodes de traitement du cancer par du glufosfamide en combinaison avec un inhibiteur du transporteur de sodium-glucose de type 2 (SGLT2) afin de bloquer la capture du glucose dans les tubules proximaux des reins, pour diminuer la toxicité rénale. L'invention concerne les domaines de la biomédecine, de la pharmacologie et de la biologie moléculaire.
Bibliography:Application Number: WO2012US53275